NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT00599937,APL93: Timing of CxT and Role of Maintenance,https://clinicaltrials.gov/study/NCT00599937,,COMPLETED,Objectives of the trial were to assess the optimal timing of chemotherapy with or after ATRA and the role of maintenance therapy.,NO,"Leukemia, Promyelocytic, Acute",DRUG: ATRA|DRUG: ATRA and or Chemo as maintenance,"For induction treatment event-free survival (EFS), calculated from the date of randomization, was the major endpoint., 2 years",,,Groupe d'etude et de travail sur les leucemies aigues promyelocytaires,"DRC lille, France",ALL,"CHILD, ADULT, OLDER_ADULT",PHASE3,576,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,APL93,1993-01,1998-12,1998-12,2008-01-24,,2008-01-24,,
